11 proyectos reciben fondos del OHSU Knight Cancer Institute para abordar necesidades locales en relación con el cáncer en todo el estado
July 28, 2023
Los proyectos incluyen iniciativas para incrementar las tasas de pruebas de detección de cáncer cervical, facilitar un grupo de apoyo para padres de pacientes pediátricos con cáncer, mejorar el índice de pacientes que se someten a pruebas de detección de cáncer colorrectal y más.
11 projects receive OHSU Knight Cancer Institute funding to address local cancer-related needs across the state
July 28, 2023
Projects include efforts to increase cervical cancer screening rates, foster a support group for parents of pediatric cancer patients, improve colorectal cancer screening, and more.
Hitting the road to bring cancer education to Oregonians
June 26, 2023
New OHSU Knight Cancer Institute mobile outreach van delivers cancer education, prevention resources to people across the state.
Salimos a la calle para educar a la población de Oregón sobre el cáncer
June 26, 2023
Nueva camioneta de extensión comunitaria del Knight Cancer Institute de OHSU lleva información y recursos de prevención a las personas de todo el estado.
Internationally renowned OHSU cancer biologist elected to the National Academy of Sciences
May 02, 2023
Lisa Coussens, Ph.D., earns one of the highest honors in the field of science and research.
Dermatólogos de OHSU detectan el cáncer de piel más pequeño del mundo
May 01, 2023
Christy Staat tenía una mancha diminuta en la mejilla que medía solo 0.65 milímetros, o 0.025 pulgadas y era casi invisible para el ojo humano. Pero, con la ayuda de tecnología no invasiva de última generación, un dermatólogo de OHSU, junto a un equipo...
OHSU dermatologists detect the world’s smallest skin cancer
May 01, 2023
Guinness World Records recognizes the team that verified the world’s smallest skin cancer, OHSU leaders emphasize the importance of early cancer detection.
Las evaluaciones de uso de tabaco cayeron durante la pandemia del COVID-19, y no han recuperado sus niveles anteriores
March 28, 2023
OHSU encabeza un estudio de alcance nacional para averiguar en qué afectó la pandemia las conversaciones de los pacientes con respecto al uso de tabaco, financiado en parte por la iniciativa Cancer MoonshotSM del National Cancer Institute.
Tobacco use assessments dropped during COVID-19 pandemic, have not recovered
March 28, 2023
OHSU leads national study on how pandemic affected patient discussions about tobacco use; funded in part by the National Cancer Institute’s Cancer Moonshot initiative.
Increasing cancer awareness, screening in underserved communities
January 12, 2023
OHSU funds projects to provide culturally relevant resources, education, workshops for people across Oregon.
OHSU Knight Cancer Institute tapped for participation in a national consortium to accelerate cancer drug discovery
December 20, 2022
As the only center in the Pacific Northwest, OHSU will collaborate with other selected centers to address unmet needs in cancer therapy.
University of Oregon football helmet auction raises more than $66,000 for breast cancer research at OHSU
October 26, 2022
OHSU Knight Cancer Institute director, employees share their appreciation in a thank-you video.
OHSU experts tapped for national Artificial Intelligence initiative
September 13, 2022
NIH-backed projects will help accelerate the use of artificial intelligence, machine learning to tackle complex research challenges for cancer, other diseases.
COVID-19 shutdowns caused delays in melanoma diagnoses, study finds
August 04, 2022
National study found that patients sought care at later stages of melanoma skin cancer, leading to potentially worse outcomes.
Nine organizations receive OHSU Knight Cancer Institute funding to address local cancer-related needs
July 13, 2022
Newly funded projects will focus on needs of Spanish-speaking communities, measure impact of financial support during cancer treatment, provide youth peer education for HPV prevention.
Three tips for safe fun in the sun
April 05, 2022
OHSU experts welcome the spring season with advice on using sunscreen, sun-protective clothing, how to perform skin checks.
OHSU researchers ‘instrumental’ in studying newly FDA-approved treatment for a form of prostate cancer
March 29, 2022
The OHSU Knight Cancer Institute is among top sites for enrolling subjects in international clinical trial.
OHSU center for pancreatic care receives $10 million gift to ‘save lives of pancreatic cancer patients and help their families’
March 11, 2022
Funding will support therapeutic advances, increase services for high-risk patients, fuel expansion in early cancer detection.
Breast cancer screening: Study shows rate of overdiagnosis not as high as previously reported
March 07, 2022
New study co-led by OHSU researchers provides most robust U.S. estimate to date, shows overdiagnosis not as ‘alarmingly frequent’ as commonly believed.
OHSU Knight Cancer Institute applauds updated Biden administration ‘Cancer Moonshot’ initiative
February 02, 2022
Institute leaders helped shape revamped plans, say OHSU will be ‘instrumental’ in contributing to the cause moving forward.
12 projects receive funding from OHSU Knight Cancer Institute to address local cancer-related needs
December 22, 2021
Projects aim to prevent lung cancer, increase awareness around risk for pancreatic cancer, provide resources to patients with cancer in rural Oregon.
‘The surgeon is the method’
November 23, 2021
Family with ‘so many touchpoints’ to OHSU travels from Seattle for pancreatic cancer surgery.
One ‘miracle’ patient’s motto: ‘Be grateful for today’
November 16, 2020
OHSU patient is second in the U.S. to use a new treatment for a rare form of cancer, defies odds with positive response.
AstraZeneca selects OHSU Knight Cancer Institute as global ‘partner of choice’
October 29, 2020
OHSU will join the company’s global precision oncology network, enhance real-time information, knowledge sharing to benefit patients.
OHSU Knight Cancer Institute awards $200,000+ to COVID-related projects around the state
October 20, 2020
Community Partnership Program funding will support food insecurity, COVID-19 outreach, technology to promote social distancing guidelines, more.
Phil and Penny Knight receive philanthropic award from the Association of American Cancer Institutes
October 14, 2020
OHSU’s Dr. Brian Druker: ‘The Knights’ incredible generosity leaves an indelible legacy in the world of cancer research.’
Husband-wife team from Stanford University tapped to lead two cancer programs at OHSU
July 09, 2020
Oncology experts will head the Division of Hematology and Medical Oncology, direct new center for experimental therapeutics.
Gov. Brown, OHSU partner on research study to inform approach for reopening Oregon
May 01, 2020
Real-time study will conduct targeted statewide COVID-19 testing, precision mapping to help safely ease physical distancing, control future outbreaks.
Time at home is the ‘perfect time’ to protect and check your skin
April 30, 2020
OHSU melanoma expert describes how to protect your skin from sun damage, prevent skin cancer while staying home.
Chocolate, candy donations bring smiles to staff and patients at OHSU Health
April 10, 2020
See’s Candies lift the spirits of patients and front-line health care workers.
Tim and Mary Boyle give $10 million to OHSU for joint center for biomedical data science
February 20, 2020
Donation supports new Oregon-based collaboration utilizing “big data” to better fight cancer and other diseases.
Investigational blood test could detect many types of cancer with one blood draw
February 18, 2020
OHSU tapped to join new early detection study; men and women aged 50 and older may be eligible to participate.
OHSU, Ionis Pharmaceuticals to develop drugs for ‘undruggable’ cancer targets
January 27, 2020
Collaboration aims to expedite discoveries for patients with leukemia.
Drug for rare gastrointestinal cancer approved by FDA
January 21, 2020
OHSU patient began treatment with a tumor more than 15 inches in length.
Harney District Hospital is one of 13 statewide projects to receive funding for cancer-related needs
January 09, 2020
OHSU Knight Cancer Institute’s Community Partnership Program has invested more than $3 million in nearly 120 projects since 2014.
A dozen opportunities to reduce inequity in cancer care
December 20, 2019
OHSU researchers lend expertise to six distinct publications on improved cancer prevention activities.
OHSU, Saint Alphonsus to provide enhanced cancer care in Idaho, eastern Oregon
November 11, 2019
As a member of the OHSU Knight Cancer Network, Saint Alphonsus will help expand cancer research, clinical trial opportunities, advanced specialized care to patients.
OHSU, OCHIN awarded $7.2 million NIH grant to implement cancer prevention strategies
October 28, 2019
New center of excellence aims to improve rates of cervical cancer screening, tobacco cessation.
International alliance sets bold research ambition to detect the (almost) undetectable
October 21, 2019
Together with collaborators in the U.S. and U.K., the OHSU Knight Cancer Institute launches new alliance solely focused on the early detection of cancer.
OHSU funds four projects across the state to increase HPV vaccination rates
July 31, 2019
Newly funded projects in Hood River, Wasco, Crook, Benton, Multnomah counties to raise awareness of cancer prevention through HPV vaccination.
‘What is funding pancreatic cancer research, Alex?’: Oregon 'Jeopardy! Teen Tournament' finalist donates to OHSU
June 27, 2019
Teen hopes donation will raise awareness for early detection research and support of treatment initiatives.
OHSU, UO join forces to combat cancer with data science
June 13, 2019
The collaboration will develop large data analyzation approaches to quickly identify cell abnormalities that lead to cancer and other diseases.
PDX Skincare Festival unites health care, skincare to reduce melanoma mortality statewide
May 15, 2019
May 18 event will mark the launch of a statewide public awareness campaign to help educate the public about the importance of skin cancer screening, early detection.
Sunil Joshi: ‘There’s a fire inside of me’ to help patients
May 13, 2019
Research Week 2019: M.D./Ph.D. student's experience translating for his family fuels his desire to treat underserved communities.
New patient-designed facilities open on Portland’s South Waterfront
April 12, 2019
OHSU’s Center for Health & Healing Building 2 and the Gary & Christine Rood Family Pavilion offer an innovative approach to patient and family experience.
Cancer startup: Drug development company acquires OHSU’s MolecularMD
March 27, 2019
By acquiring OHSU's MolecularMD, the clinical research organization ICON, based in Dublin, Ireland, has expanded its laboratory offering in molecular diagnostic testing and brings expanded testing platforms.
OHSU’s Dr. Brian Druker receives prestigious Sjöberg Prize
February 04, 2019
Awarded by the Royal Swedish Academy of Sciences, the Sjöberg Prize recognizes scientists who have made major discoveries in cancer research.
Knight Cancer Institute program funds 17 projects across the state to address cancer-related health disparities
December 21, 2018
Newly funded projects include the Asian Health & Service Center, which received a grant to help increase culturally and linguistically appropriate cancer resources for Asian communities in Oregon.
New data show sustained responses for patients with non-Hodgkin lymphoma, a form of blood cancer
December 03, 2018
OHSU physician-researcher presents updated gene transfer therapy data at conference, publishes study results in The New England Journal of Medicine.
OHSU-led effort results in largest cancer dataset of its kind
October 17, 2018
A study involving hundreds of patient samples may reveal new treatment options for patients facing an aggressive form of leukemia.
Knight Cancer Research Building opens new era in cancer research
September 07, 2018
State-of-the-art cancer research facility will support a collaborative atmosphere, bring multidisciplinary scientists together under one roof.
Palliative care may reduce suicide risk in veterans with lung cancer
August 07, 2018
New research finds patient care focused on relieving symptoms, stress reduces suicide risk by 81 percent.
OHSU Knight Cancer Institute is one of select few to offer newly approved treatment for blood cancer
July 17, 2018
Gene transfer therapy, Kymriah, now available for adults with a common form of lymphoma.
Research team discovers drug compound that stops cancer cells from spreading
June 22, 2018
Via a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.
Preeminent cancer biologist Brian Druker, M.D., receives international science award
June 19, 2018
Druker is recognized for his groundbreaking research in treating patients with leukemia.
OHSU PDX Skincare Festival aims to celebrate — and protect — your skin
May 14, 2018
Annual community event will offer free skin cancer exams, samples and services from skin care professionals, and a 5K Walk or Fun Run to benefit melanoma research.
Research Week 2018: Expanding options for patients with an aggressive form of leukemia
May 01, 2018
A new clinical trial offers alternatives.
Research Week 2018: 'Doing the right thing matters.’ Shining a light on cancer care disparities
April 30, 2018
OHSU oncologist studies how race, gender, health insurance status impacts access among vulnerable populations with cancer.
Acclaimed oncologist receives $2.5 million endowed chair to fund precision cancer research efforts
April 13, 2018
Local family funds prestigious award to enable innovative studies, mentor the next generation of physician-scientists.
Renowned cancer biologist earns national distinction
April 12, 2018
Knight Cancer Institute associate director for basic research reflects on building labs, challenging dogma, and dedicating her life to impacting cancer research.
Sneak peek: Inside the Knight Cancer Institute research building (photos)
March 29, 2018
OHSU’s 320,000 square foot cancer research building is taking shape, with completion slated for late summer 2018.
Newly approved drug is effective in patients with prostate cancer
March 27, 2018
Apalutamide significantly delayed the onset of symptoms, metastasis or death in Phase III clinical trial.
Area surrounding a tumor impacts how breast cancer cells grow
March 14, 2018
OHSU research team discovers a tumor’s ‘microenvironment’ plays a critical role in how a common type of breast cancer responds to treatment.
OHSU, PNNL create joint research co-laboratory to advance precision medicine
February 14, 2018
Pacific Northwest National Laboratory and OHSU today announced a joint collaboration to improve patient care by focusing research on highly complex sets of biomedical data, and the tools to interpret them.
OHSU Knight Cancer Institute’s Community Partnership Program reaches $2 million funding milestone
January 11, 2018
Grants support community-based cancer prevention, screening and survivorship programs in every Oregon county.
Cancer researcher finds exercise DVD significantly improves fatigue symptoms in patients with breast cancer
November 20, 2017
Patients say exercise video is helpful at all stages of diagnosis and recovery.
Patients with cancer now can see a 3-D preview of their radiation treatment
November 15, 2017
OHSU is the first in the nation to implement a virtual simulation tool into its clinical care program, allowing patients to see, hear and understand what treatment will be like.
Clinical trial results show promise for drug targeting rare stomach cancer
November 14, 2017
Early results from the BLU-285 study demonstrate efficacy for patients with gastrointestinal stromal tumors.
‘No words’: Joshi Alumkal, M.D., receives surprise $2.5 million endowed chair from Kuni Foundation
November 07, 2017
The Kuni Foundation's award will support new research in the field of prostate cancer.
Internationally renowned scientist Gordon B. Mills recruited to lead precision oncology for the OHSU Knight Cancer Institute
October 10, 2017
One of the most highly cited medical scientists in the world, Mills brings a breadth of research, leadership experience to OHSU.
OHSU Doernbecher is first hospital in Pacific Northwest to offer new FDA-approved treatment for advanced leukemia
September 21, 2017
The first FDA-approved gene transfer therapy for patients with acute lymphoblastic leukemia will be available at a handful of approved hospitals, including OHSU Doernbecher.
How much does it cost to bring a cancer drug to market?
September 11, 2017
A new study focused on the research and development spending of some pharmaceutical companies found the cost of bringing a cancer drug to market was significantly less than previously reported.
NIH selects OHSU Knight Cancer Institute to co-lead largest national database for pediatric cancer, rare disease research
August 15, 2017
OHSU will collaborate with other other teams to establish a pediatric cancer and rare disease data program--a first for the pediatric research community.
OHSU Knight Cancer Institute earns National Cancer Institute’s highest distinction
July 10, 2017
OHSU Knight Cancer Institute has been awarded the National Cancer Institute’s, NCI, premier status: Comprehensive Cancer Center.
OHSU Knight Cancer Institute and Pacific Northwest National Laboratory team up to focus on a complex form of leukemia
June 27, 2017
The Office of Cancer Clinical Proteomics Research (OCCPR) at the National Cancer Institute (NCI) announced the institutes that will comprise the Proteogenomic Translational Research Centers, a group created to collaborate with NCI-sponsored clinical trials.
Technology expert joins the OHSU Knight Cancer Institute’s center for cancer early detection
June 22, 2017
Today the OHSU Knight Cancer Institute announced that internationally renowned bioengineering and technology expert Mike Heller, Ph.D., will join the institute’s Cancer Early Detection Advanced Research Center, or CEDAR, to lead its technology efforts.
Study finds nearly half of female cancer survivors experience symptoms of nerve damage, experience more falls well after treatment
June 19, 2017
A study of more than 500 cancer survivors found that many years after completing treatment, nearly half of women cancer survivors continued to experience chemotherapy-induced peripheral neuropathy, CIPN.
Local pancreatic cancer survivor continues fight on hit television show “American Ninja Warrior”
June 09, 2017
“Despite everything I’ve been through, in some ways, I’m in the best shape of my life now, as a cancer survivor,” says Joe Heiden, a competitor on the television program "American Ninja Warrior."
Now serving Malheur and Wallowa counties: OHSU Knight Cancer Institute Community Partnership Program
June 08, 2017
The Community Partnership Program will fund cancer-related projects in every county in Oregon.
OHSU Knight Cancer Institute selected to join prestigious national consortium, receive $9.2 million
May 25, 2017
The National Cancer Institute has awarded a research team at the OHSU Knight Cancer Institute $9.2 million over five years to serve as a Research Center in the NCI’s Cancer Systems Biology Consortium, or CSBC.
2017 ‘War on Skin Cancer Event’ aims to better understand why family matters with a melanoma diagnosis
May 15, 2017
May is Melanoma Awareness Month, and the OHSU Knight Cancer Institute will again hold the “War on Skin Cancer Event” Saturday, May 20, from 9 a.m. to 2 p.m., to educate the community about sun safety and skin cancer risk factors.
Research Week 2017: Leaving your comfort zone, ‘cross training’ in conducting exercise research
May 02, 2017
Kerri Winters-Stone, Ph.D., researches the use of physical activity to prevent and manage chronic disease. Her studies have shown that cancer survivors can benefit from exercise that reverses treatment-related side effects and symptoms.
Research Week 2017: Why should anyone care about aflatoxins? Communicating the need for basic science around the world
May 01, 2017
Stephen Lloyd's recent research, published in the Proceedings of the National Academy of Sciences, drew upon his expertise as a cancer biologist and focused on a global health problem affecting hundreds of thousands of individuals in Southeast Asia and Sub-Saharan Africa, where a specific class of toxic compounds, called aflatoxins, are commonly found in food sources.
May 20: Ask any skin question, see a photo tribute, walk to raise awareness at OHSU’s 2017 'War on Skin Cancer Event'
April 24, 2017
A free War on Skin Cancer Event at OHSU gives attendees the chance to talk with experts, participate in fundraising, evaluate potential risk for melanoma, and more.
In search of treatment for a perilous form of leukemia
March 28, 2017
There’s an urgency in Anupriya Agarwal’s voice when she talks about her acute myeloid leukemia research: “We need to do something beyond what we’ve already done,” she said. “The treatment hasn’t changed in decades, and that can’t be our only answer.”
OHSU physician awarded $2 million to investigate health care practices that 'don’t work'
March 27, 2017
Vinay Prasad, M.D., M.P.H., has been awarded a $2 million grant to support an effort to uncover treatments and tests that are contradicted by reliable evidence. The three-year project calls for sharing the findings via a public website and developing teaching modules that can be incorporated into medical school or residency curricula.
New England Journal of Medicine publishes long-term results of Gleevec® for patients with chronic myeloid leukemia
March 08, 2017
The New England Journal of Medicine published results from a nearly 11-year follow-up study, that showed an estimated overall survival rate of 83.3 percent. According to the National Cancer Institute, prior to Gleevec’s 2001 FDA approval, fewer than 1 in 3 CML patients survived five years past diagnosis.
The OHSU Knight – Legacy Health Cancer Collaborative program expands to Clark County
March 02, 2017
The OHSU Knight Cancer Institute and Legacy Health have signed business agreements with The Vancouver Clinic, or TVC, to expand their network of integrated adult cancer care clinics to southwest Washington. The agreement is the latest addition to the OHSU Knight-Legacy Health Cancer Collaborative, established in 2013.
Gene mutations cause leukemia, but which ones?
February 21, 2017
Research published today in the journal Oncotarget, sought to better understand one “typo” in a standard leukemia assay, or test. While studying cancer biology and completing his doctorate at the OHSU Knight Cancer Institute, Kevin Watanabe-Smith, Ph.D., encountered a new problem: an issue with the model system itself.
Mole Mapper app ‘crowd-sources’ photos for skin cancer research, prevention
February 14, 2017
Commenting on recent research findings from a team at Stanford University, Sancy Leachman, M.D., Ph.D., director of the OHSU Knight Cancer Institute’s Melanoma Research Program and chair of the Department of Dermatology in the OHSU School of Medicine, co-authored a Nature News and Views perspective that heralded artificial intelligence, or AI, an important step in the “final frontier” in cancer diagnosis.
Cancer survivor thanks her caregivers with a song
January 23, 2017
Suse Skinner, 70, is fighting her second battle with cancer. In 2005 she was diagnosed with breast cancer, then in August 2016 she was admitted to OHSU for her first induction chemotherapy session for acute myeloid leukemia, where she underwent 24/7 chemotherapy for six days followed by six weeks of recovery.
Low-dose aspirin may slow growth of colon, pancreatic cancer cells
January 19, 2017
An OHSU and Oregon State University study finds aspirin may slow the spread of some types of colon and pancreatic cancer cells, Their findings are published in the American Journal of Physiology—Cell Physiology.
Should cancer doctors disclose financial conflicts of interest when they tweet?
January 17, 2017
Conversations centered on health care are increasingly taking place on social media. For example, doctors, patients, advocates, the FDA and members of the pharmaceutical industry frequently interact on Twitter, discussing new drugs and devices.
OHSU Knight Cancer Institute strongly endorses new HPV vaccine recommendations
January 11, 2017
Recognizing a critical need to improve national vaccination rates for human papillomavirus, or HPV, the OHSU Knight Cancer Institute has united with all 69 National Cancer Institute-designated cancer centers in issuing a joint statement in support of recently revised recommendations from the Centers for Disease Control and Prevention.
Community Partnership Program funds 10 new cancer research projects around the state
December 12, 2016
The OHSU Knight Cancer Institute has announced grant funding to 10 community-led projects around the state in the latest funding cycle for its Community Partnership Program.
Treating cancer, mental health neglect in rural America
December 08, 2016
OHSU Knight Cancer Institute oncologist publishes New England Journal of Medicine “Perspective” on her experience treating a patient in rural Oregon with breast cancer and mental illness.
Study: Enhancing cancer response to radiation
November 28, 2016
OHSU researcher Sudarshan Anand, Ph.D., has a contemporary analogy to describe microRNA: “I sometimes compare MicroRNA to tweets — they’re short, transient and constantly changing.”
Depression symptoms tied to lung cancer survival, study finds
November 01, 2016
OHSU research published in the Journal of Clinical Oncology shows that patients with lung cancer who have symptoms of depression have overall lower survival rates than those without depression symptoms.
Oregon women sought for study on the potential connection between blood cancers and heart disease
October 29, 2016
As we age, as many as 10 to 30 percent of us spontaneously carry mutations in our blood cells that put us at risk for blood cancers and heart disease. Researchers at OHSU are leading a unique study for women aged 65 and older called WEAR, or Women.
